|
Canada-0-LaboratoriesTesting 公司名錄
|
公司新聞:
- Executive team - Merck. com
Get to know Merck's Executive team, lead by CEO and president Robert M Davis
- Belén Garijo - Company - Merck
Belén Garijo became Chair of the Executive Board and CEO of Merck in May 2021 Since then, she has transformed the company to strengthen its position as a global science and technology leader
- Belén Garijo - Wikipedia
In May 2021, she was named chief executive officer of Merck, following Stefan Oschmann [7][8] At the time, she was the first woman to head a company listed in Germany's stock market index DAX; she also became one of the top earners among the executives of DAX companies
- Merck Appoints Kai Beckmann as Next CEO Effective May 2026
Merck has announced that Kai Beckmann will take over as Chair of the Executive Board and Chief Executive Officer on 1 May 2026 He will succeed Belén Garijo, who has led the company as CEO since 2021 and will remain in place until the end of her tenure
- Chairman and Chief Executive Officer, Merck Co. - LinkedIn
I’m honored to serve as chairman and CEO for Merck, known as MSD outside the United States and Canada Under my leadership, the company remains fully committed to leading-edge science and
- Merck KGaA names new CEO amid geopolitical tensions
Belén Garijo, who steered Merck KGaA through the COVID-19 pandemic, will step down as CEO of the German healthcare and electronics conglomerate Garijo will end her five-year tenure as planned
- Germany’s Merck KGaA Names Kai Beckmann as Incoming Chair, CEO
Germany’s Merck MRK -1 00% KGaA named Kai Beckmann as its incoming chief executive officer and chair of the board, and said he would replace the outgoing Belen Garijo from May
- Robert M. Davis - Merck. com
Rob Davis is chairman of the board and chief executive officer of Merck Co , Inc Previously, Rob served as Merck’s president, responsible for the company’s operating divisions — Human Health, Animal Health, Manufacturing and Merck Research Laboratories
- Merck CEO Kai Beckmann from 2026 – Garijo hands over as planned
Kai Beckmann will take over as CEO of Merck on May 1, 2026 He succeeds Belén Garijo, whose term of office ends as planned at the end of April
- Kai Beckmann to Succeed Belén Garijo as CEO of Merck as of May 2026
The Board of Partners of E Merck KG appointed Kai Beckmann as future Chair of the Executive Board and CEO of Merck He will take over this position on May 1, 2026, from Belén Garijo, who will continue to lead the company until the end of her tenure, ensuring a seamless transition
|
|